Cyclerion Therapeutics Inc (CYCN)

Cyclerion Therapeutics Inc (CYCN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 14, 2026: market cap $2.2M; returns 1 week -85.7%, 1 year +41.8%.

Cyclerion Therapeutics Inc. (CYCN) is a clinical-stage biopharmaceutical company that has undergone a significant strategic transformation, relaunching in late 2025 as a neuropsychiatric company. Its current primary focus is the development of novel therapies for neuropsychiatric diseases, specifically targeting treatment-resistant depression (TRD) with its lead program, CYC-126.

Groups CYCN belongs to

• Recent Reverse Splits

CYCN financial model: income statement, cash flow and balance sheet